ELISIGEN
LIVE

Serial Number

79458054

Owner

ELISIGEN INC.

Filing Date

Jun 23, 2026

Add to watchlist:

No watchlists yet
View on USPTO

ELISIGEN Trademark

Serial Number: 79458054

ELISIGEN is a trademark filed by ELISIGEN INC. on June 23, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

ELISIGEN INC. (3 trademarks)

402-2, Sanhakgwan, 145 Anam-ro
Seoul 02841 , KR

Entity Type: 99

Trademark Details

Filing Date

June 23, 2026

Registration Date

Not Registered

Goods & Services

Wholesale distributorships in the field of pharmaceutical preparations for the treatment of sensory organ disorders; wholesale distributorships in the field of pharmaceutical preparations for the treatment of peripheral nervous system disorders; wholesale distributorships in the field of pharmaceutical preparations for the treatment of central nervous system disorders; wholesale distributorships in the field of analgesics; wholesale distributorships in the field of immunomodulators; wholesale distributorships in the field of vaccines; wholesale distributorships in the field of chemical preparations for use in the manufacture of pharmaceuticals; wholesale distributorships in the field of biological preparations for medical and veterinary purposes; wholesale distributorships in the field of pharmaceutical preparations for the treatment of allergies; wholesale distributorships in the field of cosmetics.

Research in the field of pharmacogenetics; research and development of gene-based pharmaceuticals; research and development in the field of gene expression systems; research in the field of gene therapy; research in the field of gene editing technologies; scientific research in the field of genetics; genetic testing for scientific research purposes; pharmaceutical research and development; research and development services in the field of cosmetics; food research.

Nucleic acid sequences for medical and veterinary purposes; chemical reagents for dna analysis for medical purposes; cell therapy preparations for medical purposes; synthetic peptides for pharmaceutical purposes; cells for medical purposes; ophthalmic preparations; pharmaceutical preparations for treating sensory organ disorders; pharmaceutical preparations for treating peripheral nervous system disorders; pharmaceutical preparations for the treatment of tinnitus; pharmaceutical preparations for the treatment of central nervous system diseases and disorders; pain relief medication; analgesics; pharmaceutical preparations for use in immunomodulation therapies; vaccines; tranquilizers; chemical preparations for pharmaceutical purposes; biological preparations for medical and veterinary purposes; diagnostic preparations for medical purposes; drug delivery agents in the form of coatings for tablets that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparations for the prevention and treatment of allergies.

Filing History

APPLICATION FILING RECEIPT MAILED
Sep 10, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 10, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 10, 2026 REPR